Skip to main content

Advertisement

SpringerLink
Log in

Retinoblastoma: A Global Perspective

  • Pediatric Ophthalmology (S Robbins, Section Editor)
  • Published:
Current Ophthalmology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This paper will review the current literature on retinoblastoma (Rb) treatment and epidemiology worldwide, with a focus on interventions to improve survival in developing countries.

Recent Findings

In North America, Europe, and Japan, treatment for Rb has improved dramatically over the last few decades. In developing countries, however, numerous issues continue to limit Rb care, including access to specialists, cost of conventional treatments, and social/cultural considerations that contribute to delayed presentation. Some countries have instituted programs to address these barriers. Researchers have also been developing low-cost technology to improve screening techniques. These initiatives hold promise for the future of Rb treatment on a global scale.

Summary

A multidimensional approach to Rb care is necessary to bridge the gap in survival worldwide. Programs that address social/cultural barriers to care must be combined with partnerships between developed and developing countries to make state-of-the-art treatment available worldwide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •Of importance ••Of major importance

  1. Butros LJ, Abramson DH, Dunkel IJ. Delayed diagnosis of retinoblastoma: analysis of degree, cause, and potential consequences. Pediatrics. 2002;109(3):E45.

    Article  PubMed  Google Scholar 

  2. Abramson DH, Beaverson K, Sangani P, Vora RA, Lee TC, Hochberg HM, et al. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. Pediatrics. 2003;112:1248–55.

    Article  PubMed  Google Scholar 

  3. Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS, et al. Retinoblastoma. Lancet. 2012;379(9824):1436–46.

    Article  PubMed  Google Scholar 

  4. MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE. Retinoblastoma incidence and survival in European children (1978–1997). Eur J Cancer. 2006;42(13):2092–102.

    Article  CAS  PubMed  Google Scholar 

  5. Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975–2004. Br J Ophthal. 2009;93(1):24–7.

    Article  CAS  Google Scholar 

  6. Gallie BL, Zhao J, Vandezande K, White A, Chan HS. Global issues and opportunities for optimized retinoblastoma care. Pediatr Blood Cancer. 2007;49(7 Suppl):1083–90.

    Article  PubMed  Google Scholar 

  7. Canturk S, Qaddoumi I, Khetan V, Ma Z, Furmanchuk A, Antoneli CB, et al. Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol. 2010;94(11):1432–6.

    Article  CAS  PubMed  Google Scholar 

  8. Carrim ZI, Kajaige J, Bowman RJ, Lavy TE, Scanlan P. First-year experience of chemotherapy for advanced retinoblastoma in Tanzania: disease profile, outcomes, and challenges in 2008. J Pediatr Ophthalmol Strabismus. 2012;49(3):176–83.

    Article  PubMed  Google Scholar 

  9. Kazadi Lukusa A, Aloni MN, Kadima-Tshimanga B, Mvitu-Muaka M, Gini Ehungu JL, Ngiyulu R, et al. Retinoblastoma in the Democratic Republic of Congo: 20-year review from a tertiary hospital in Kinshasa. J Cancer Epidemiol. 2012;2012:920468.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Gichigo EN, Kariuki-Wanyoike MM, Kimani K, Nentwich MM. Retinoblastoma in Kenya: survival and prognostic factors. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 2015;112(3):255–60.

    Article  CAS  Google Scholar 

  11. Bowman RJ, Mafwiri M, Luthert P, Luande J, Wood M. Outcome of retinoblastoma in East Africa. Pediatr Blood Cancer. 2008;50(1):160–2.

    Article  CAS  PubMed  Google Scholar 

  12. Essuman V, Ntim-Amponsah CT, Akafo S, Renner L, Edusei L. Presentation of retinoblastoma at a paediatric eye clinic in Ghana. Ghana Med J. 2010;44(1):10–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Jamalia R, Sunder R, Alagaratnam J, Goh PP. Retinoblastoma Registry report—Hospital Kuala Lumpur experience. Med J Malaysia 2010; 65 Suppl A:128–130.

  14. •• Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93(9):1129–31. Although published >3 years ago, Kivela presents a compelling argument for the urgency of addressing global disparities in Rb care, calculating that death from Rb worldwide could decrease 88% if survival rates in developing countries improved

    Article  PubMed  Google Scholar 

  15. Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2009;93(1):21–3.

    Article  CAS  PubMed  Google Scholar 

  16. Wong JR, Tucker MA, Kleinerman RA, Devesa SS. Retinoblastoma incidence patterns in the US surveillance, epidemiology, and end results program. JAMA Ophthalmol. 2014;132(4):478–83.

    Article  PubMed  Google Scholar 

  17. • Truong B, Green AL, Friedrich P, Ribeiro KB, Rodriguez-Galindo C. Ethnic, racial, and socioeconomic disparities in retinoblastoma. JAMA Pediatr. 2015;169(12):1096–104. This recent study revealed concerns about unequal access to Rb care in the USA, linking race, socioeconomic status, and lower education to advanced disease

    Article  PubMed  Google Scholar 

  18. Magrath I, Steliarova-Foucher E, Epelman S, Ribeiro RC, Harif M, Li CK, et al. Paediatric cancer in low-income and middle-income countries. Lancet Oncol. 2013;14(3):e104–16.

    Article  PubMed  Google Scholar 

  19. Parkin DM, Stiller CA, Draper GJ, Bieber CA. The international incidence of childhood cancer. Int J Cancer. 1988;42(4):511–20.

    Article  CAS  PubMed  Google Scholar 

  20. Schultz KR, Ranade S, Neglia JP, Ravindranath Y. An increased relative frequency of retinoblastoma at a rural regional referral hospital in Miraj, Maharashtra, India. Cancer. 1993;72(1):282–6.

    Article  CAS  PubMed  Google Scholar 

  21. Stiller CA, Parkin DM. Geographic and ethnic variations in the incidence of childhood cancer. British Med Bull. 1996;52(4):682–703.

    Article  CAS  Google Scholar 

  22. Fajardo-Gutierrez A, Juarez-Ocana S, Gonzalez-Miranda G, Palma-Padilla V, Carreon-Cruz R, Ortega-Alvarez MC, et al. Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic: importance of the Cancer registry. BMC Cancer. 2007;7:68.

    Article  PubMed  PubMed Central  Google Scholar 

  23. de Camargo B, de Oliveira Ferreira JM, de Souza RR, Ferman S, de Oliveira SM, Pombo-de-Oliveira MS. Socioeconomic status and the incidence of non-central nervous system childhood embryonic tumours in Brazil. BMC Cancer. 2011;11:160.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Ochicha O, Gwarzo AK, Gwarzo D. Pediatric malignancies in Kano, Northern Nigeria. World J Pediatr. 2012;8(3):235–9.

    Article  PubMed  Google Scholar 

  25. Boubacar T, Fatou S, Fousseyni T, Mariam S, Fatoumata DT, Toumani S, et al. A 30-month prospective study on the treatment of retinoblastoma in the Gabriel Toure Teaching Hospital, Bamako, Mali. Br J Ophthalmol. 2010;94(4):467–9.

    Article  PubMed  Google Scholar 

  26. Slone JS, Chunda-Liyoka C, Perez M, Mutalima N, Newton R, Chintu C, et al. Pediatric malignancies, treatment outcomes and abandonment of pediatric cancer treatment in Zambia. PLoS One. 2014;9(2):e89102.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Pearce MS, Parker L. Childhood cancer registrations in the developing world: still more boys than girls. Int J Cancer. 2001;91(3):402–6.

    Article  CAS  PubMed  Google Scholar 

  28. Grossniklaus HE. Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture. Am J Ophthalmol. 2014;158(5):875–91.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Shields CL, Meadows AT, Leahey AM, Shields JA. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina. 2004;24(6):849–62.

    Article  PubMed  Google Scholar 

  30. Pratt CB, Crom DB, Howarth C. The use of chemotherapy for extraocular retinoblastoma. Med Pediatr Oncol. 1985;13(6):330–3.

    Article  CAS  PubMed  Google Scholar 

  31. Kingston JE, Hungerford JL, Plowman PN. Chemotherapy in metastatic retinoblastoma. Ophthalmic Pediatr Genet. 1987;8(1):69–72.

    Article  CAS  Google Scholar 

  32. Greenwald MJ, Strauss LC. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy. Ophthalmology. 1996;103(12):1989–97.

    Article  CAS  PubMed  Google Scholar 

  33. Mendoza PR, Grossniklaus HE. Therapeutic options for retinoblastoma. Cancer Control. 2016;23(2):99–109.

    PubMed  Google Scholar 

  34. Epstein JA, Shields CL, Shields JA. Trends in the management of retinoblastoma: evaluation of 1,196 consecutive eyes during 1974 to 2001. J Pediatr Ophthalmol Strabismus. 2003;40(4):196–203. 217-198

    PubMed  Google Scholar 

  35. Shields CL, Gorry T, Shields JA. Outcome of eyes with unilateral sporadic retinoblastoma based on the initial external findings by the family and the pediatrician. J Pediatr Ophthalmol Strabismus. 2004;41(3):143–9. 172-143

    PubMed  Google Scholar 

  36. • Abramson DH, Shields CL, Munier FL, Chantada GL. Treatment of retinoblastoma in 2015: agreement and disagreement. JAMA Ophthalmology. 2015;133(11):1341–7. Authors from major treatment centers in the USA, Argentina, and Europe discuss important treatment advances in the last 10 years

    Article  PubMed  Google Scholar 

  37. Shields CL, Jorge R, Say EA, Magrath G, Alset A, Caywood E, et al. Unilateral retinoblastoma managed with intravenous chemotherapy versus intra-arterial chemotherapy. Outcomes based on the International Classification of Retinoblastoma. Asia Pac J Ophthalmol. 2016;5(2):97–103.

    Article  CAS  Google Scholar 

  38. Chantada GL, Qaddoumi I, Canturk S, Khetan V, Ma Z, Kimani K, et al. Strategies to manage retinoblastoma in developing countries. Pediatr Blood Cancer. 2011;56(3):341–8.

    Article  PubMed  Google Scholar 

  39. Qaddoumi I, Nawaiseh I, Mehyar M, Razzouk B, Haik BG, Kharma S, et al. Team management, twinning, and telemedicine in retinoblastoma: a 3-tier approach implemented in the first eye salvage program in Jordan. Pediatr Blood Cancer. 2008;51(2):241–4.

    Article  PubMed  Google Scholar 

  40. Chang CY, Chiou TJ, Hwang B, Bai LY, Hsu WM, Hsieh YL. Retinoblastoma in Taiwan: survival rate and prognostic factors. Jpn J Ophthalmol. 2006;50(3):242–9.

    Article  PubMed  Google Scholar 

  41. Sitorus RS, Moll AC, Suhardjono S, Simangunsong LS, Riono P, Imhof S, et al. The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common. Ophthalmic Genet. 2009;30(1):31–6.

    Article  PubMed  Google Scholar 

  42. •• Waddell KM, Kagame K, Ndamira A, Twinamasiko A, Picton SV, Simmons IG, et al. Improving survival of retinoblastoma in Uganda. Br J Ophthalmol. 2015;99(7):937–42. This study exemplifies a multidimensional strategy to provide affordable chemotherapy while addressing social barriers to Rb care in Africa

    Article  PubMed  Google Scholar 

  43. Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2016;100(2):172–8.

    Article  PubMed  Google Scholar 

  44. Jubran RF, Erdreich-Epstein A, Butturini A, Murphree AL, Villablanca JG. Approaches to treatment for extraocular retinoblastoma: Children’s Hospital Los Angeles experience. Journal Pediatr Hematol Oncol. 2004;26(1):31–4.

    Article  Google Scholar 

  45. Atchaneeyasakul LO, Wongsiwaroj C, Uiprasertkul M, Sanpakit K, Thephamongkhol K, Trinavarat A. Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study. Jpn J Ophthalmol. 2009;53(1):35–9.

    Article  PubMed  Google Scholar 

  46. Menon BS, Alagaratnam J, Juraida E, Mohamed M, Ibrahim H, Naing NN. Late presentation of retinoblastoma in Malaysia. Pediatr Blood Cancer. 2009;52(2):215–7.

    Article  PubMed  Google Scholar 

  47. Luna-Fineman S, Barnoya M, Bonilla M, Fu L, Baez F, Rodriguez-Galindo C. Retinoblastoma in Central America: report from the Central American Association of Pediatric Hematology Oncology (AHOPCA). Pediatr Blood Cancer. 2012;58(4):545–50.

    Article  PubMed  Google Scholar 

  48. Waddell KM, Kagame K, Ndamira A, Twinamasiko A, Picton SV, Simmons IG, et al. Clinical features and survival among children with retinoblastoma in Uganda. Br J Ophthalmol. 2015;99(3):387–90.

    Article  PubMed  Google Scholar 

  49. Rodrigues KE, Latorre Mdo R, de Camargo B. Delayed diagnosis in retinoblastoma. J Pediatr (RioJ). 2004;80(6):511–6.

    Article  Google Scholar 

  50. Bai S, Ren R, Li B, Xu X, Zhao B, Gao F, et al. Delay in the diagnosis of retinoblastoma in China. Acta Ophthalmol. 2011;89(1):e72–4.

    Article  PubMed  Google Scholar 

  51. Zhao J, Li S, Shi J, Wang N. Clinical presentation and group classification of newly diagnosed intraocular retinoblastoma in China. Br J Ophthalmol. 2011;95(10):1372–5.

    Article  PubMed  Google Scholar 

  52. Sah KP, Saiju R, Roy P, Kafle S. Retinoblastoma: ten years experience at Kanti Children’s Hospital. J Nepal Med Assoc. 2013;52(192):576–9.

    Google Scholar 

  53. Finger PT, Harbour JW, Karcioglu ZA. Risk factors for metastasis in retinoblastoma. Survey Ophthalmol. 2002;47(1):1–16.

    Article  Google Scholar 

  54. Rubin CM, Robison LL, Cameron JD, Woods WG, Nesbit Jr ME, Krivit W, et al. Intraocular retinoblastoma group V: an analysis of prognostic factors. J Clin Oncol. 1985;3(5):680–5.

    Article  CAS  PubMed  Google Scholar 

  55. Schvartzman E, Chantada G, Fandino A, de Davila MT, Raslawski E, Manzitti J. Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol. 1996;14(5):1532–6.

    Article  CAS  PubMed  Google Scholar 

  56. Antoneli CB, Steinhorst F, de Cassia Braga Ribeiro K, Novaes PE, Chojniak MM, Arias V, et al. Extraocular retinoblastoma: a 13-year experience. Cancer. 2003;98(6):1292–8.

    Article  PubMed  Google Scholar 

  57. Chantada G, Fandino A, Casak S, Manzitti J, Raslawski E, Schvartzman E. Treatment of overt extraocular retinoblastoma. Med Pediatr Oncol. 2003;40(3):158–61.

    Article  PubMed  Google Scholar 

  58. Gunduz K, Muftuoglu O, Gunalp I, Unal E, Tacyildiz N. Metastatic retinoblastoma clinical features, treatment, and prognosis. Ophthalmology. 2006;113(9):1558–66.

    Article  PubMed  Google Scholar 

  59. Leal-Leal CA, Rivera-Luna R, Flores-Rojo M, Juarez-Echenique JC, Ordaz JC, Amador-Zarco J. Survival in extra-orbital metastatic retinoblastoma: treatment results. Clin Transl Oncol. 2006;8(1):39–44.

    Article  PubMed  Google Scholar 

  60. Huang D, Zhang Y, Zhang W, Wang Y, Zhang P, Hong L, et al. Study on clinical therapeutic effect including symptoms, eye preservation rate, and follow-up of 684 children with retinoblastoma. Eur J Ophthalmol. 2013;23(4):532–8.

    Article  PubMed  Google Scholar 

  61. • Erwenne CM, Franco EL. Age and lateness of referral as determinants of extra-ocular retinoblastoma. Ophthalmic Pediatr Genet. 1989;10(3):179–84. Although not recent, this is the first study to correlate longer delay and older age with decreased survival from Rb

    Article  CAS  Google Scholar 

  62. Karcioglu ZA, Al-Mesfer SA, Abboud E, Jabak MH, Mullaney PB. Workup for metastatic retinoblastoma. A review of 261 patients. Ophthalmology. 1997;104(2):307–12.

    Article  CAS  PubMed  Google Scholar 

  63. Chantada G, Fandino A, Manzitti J, Urrutia L, Schvartzman E. Late diagnosis of retinoblastoma in a developing country. Arch Dis Child. 1999;80(2):171–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M. Retinoblastoma in Iran: outcomes in terms of patients’ survival and globe survival. Br J Ophthalmol. 2009;93(1):28–32.

    Article  CAS  PubMed  Google Scholar 

  65. Saiju R, Moore G, Shrestha U, Shrestha MK, Ruit S. Retinoblastoma: geographic distribution and presentation at a tertiary eye care centre in Kathmandu. Nepal Nepalese J Ophthalmol. 2013;5(2):169–76.

    CAS  Google Scholar 

  66. Subramaniam S, Rahmat J, Rahman NA, Ramasamy S, Bhoo-Pathy N, Pin GP, et al. Presentation of retinoblastoma patients in Malaysia. Asian Pac J Cancer Prev. 2014;15(18):7863–7.

    Article  PubMed  Google Scholar 

  67. Okimoto S, Nomura K. Clinical manifestations and treatment of retinoblastoma in Kobe Children’s Hospital for 16 years. J Pediatr Ophthalmol Strabismus. 2014;51(4):222–9.

    Article  PubMed  Google Scholar 

  68. Leal-Leal C, Flores-Rojo M, Medina-Sanson A, Cerecedo-Diaz F, Sanchez-Felix S, Gonzalez-Ramella O, et al. A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol. 2004;88(8):1074–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Bekibele CO, Ayede AI, Asaolu OO, Brown BJ. Retinoblastoma: the challenges of management in Ibadan. Nigeria J Pediatr Hematol Oncol. 2009;31(8):552–5.

    Article  PubMed  Google Scholar 

  70. Olteanu C, Dimaras H. Enucleation refusal for retinoblastoma: a global study. Ophthalmic Genet. 2016;37(2):137–43.

    PubMed  Google Scholar 

  71. Sethi S, Pushker N, Kashyap S, Sharma S, Mehta M, Bakhshi S, et al. Extraocular retinoblastoma in Indian children: clinical, imaging and histopathological features. Int J Ophthalmol. 2013;6(4):481–6.

    PubMed  PubMed Central  Google Scholar 

  72. Ramirez-Ortiz MA, Ponce-Castaneda MV, Cabrera-Munoz ML, Medina-Sanson A, Liu X, Orjuela MA. Diagnostic delay and sociodemographic predictors of stage at diagnosis and mortality in unilateral and bilateral retinoblastoma. Cancer Epidemiol Biomark Prev. 2014;23(5):784–92.

    Article  Google Scholar 

  73. Leal-Leal CA, Dilliz-Nava H, Flores-Rojo M, Robles-Castro J. First contact physicians and retinoblastoma in Mexico. Pediatr Blood Cancer. 2011;57(7):1109–12.

    Article  PubMed  Google Scholar 

  74. Kumar A, Moulik NR, Mishra RK, Kumar D. Causes, outcome and prevention of abandonment in retinoblastoma in India. Pediatr Blood Cancer. 2013;60(5):771–5.

    Article  PubMed  Google Scholar 

  75. Rodriguez-Galindo C, Wilson MW, Chantada G, Fu L, Qaddoumi I, Antoneli C, et al. Retinoblastoma: one world, one vision. Pediatrics. 2008;122(3):e763–70.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Hill JA, Kimani K, White A, Barasa F, Livingstone M, Gallie BL, et al. Achieving optimal cancer outcomes in East Africa through multidisciplinary partnership: a case study of the Kenyan National Retinoblastoma Strategy group. Glob Health. 2016;12(1):23.

    Article  Google Scholar 

  77. WHO model list of essential medicines for children (2015), 5th edition. Available at: http://www.who.int/medicines/publications/essentialmedicines/en/. Accessed 23 September 2016.

  78. Arora RS, Challinor JM, Howard SC, Israels T. Improving care for children with cancer in low- and middle-income countries—a SIOP PODC initiative. Pediatr Blood Cancer. 2016;63(3):387–91.

    Article  PubMed  Google Scholar 

  79. •• Leander C, Fu LC, Pena A, Howard SC, Rodriguez-Galindo C, Wilimas JA, et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer. 2007;49(6):817–9. The authors describe a cost-effective educational campaign to improve Rb awareness, with impressive results. This initiative is frequently referenced by other authors as an example of a successful Rb awareness program to counteract the problem of delayed presentation in developing countries

    Article  PubMed  Google Scholar 

  80. •• Al-Nawaiseh I, Jammal HM, Khader YS, Jaradat I, Barham R. Retinoblastoma in Jordan, 2003–2013: ocular survival and associated factors. Ophthalmic Epidemiol. 2014;21(6):406–11. This manuscript provides powerful evidence that collaboration between developed and developing countries can improve treatment compliance and ultimately Rb survival

    Article  PubMed  Google Scholar 

  81. Wilimas JA, Wilson MW, Haik BG, Barnoya M, Fu L, Castellanos M, et al. Development of retinoblastoma programs in Central America. Pediatr Blood Cancer. 2009;53(1):42–6.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Su WW, Kao LY. Retinoblastoma in Taiwan: the effect of a government-sponsored national health insurance program on the treatment and survival of patients with retinoblastoma. J Pediatr Ophthalmol Strabismus. 2006;43(6):358–62.

    PubMed  Google Scholar 

  83. Lim FP, Soh SY, Iyer JV, Tan AM, Swati H, Quah BL. Clinical profile, management, and outcome of retinoblastoma in Singapore. J Pediatr Ophthalmol Strabismus. 2013;50(2):106–12.

    Article  PubMed  Google Scholar 

  84. American Academy of Pediatrics, Red reflex examination in neonates, infants, and children. Pediatrics. 2008;122(6):1401–4.

  85. Li J, Coats DK, Fung D, Smith EO, Paysse E. The detection of simulated retinoblastoma by using red-reflex testing. Pediatrics. 2010;126(1):e202–7.

    Article  PubMed  Google Scholar 

  86. Ventura G, Cozzi G. Red reflex examination for retinoblastoma. Lancet. 2012;380(9844):803–4.

    Article  PubMed  Google Scholar 

  87. Alfaar AS, Nour R, Bakry MS, Kamal M, Hassanain O, Labib RM, et al. 2016. A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt. Int Ophthalmol

  88. Shanmugam MP, Mishra DK, Madhukumar R, Ramanjulu R, Reddy SY, Rodrigues G. Fundus imaging with a mobile phone: a review of techniques. Indian J Ophthalmol. 2014;62(9):960–2.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Abdolvahabi A, Taylor BW, Holden RL, Shaw EV, Kentsis A, Rodriguez-Galindo C, et al. Colorimetric and longitudinal analysis of leukocoria in recreational photographs of children with retinoblastoma. PLoS One. 2013;8(10):e76677.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. https://itunes.apple.com/us/app/white-eye-detector/id904042354?mt=8.

Download references

Acknowledgements

The authors would like to acknowledge Dr. Joan O’Brien, MD (Chairman, Department of Ophthalmology, University of Pennsylvania) for offering insight into the future of telemedicine screening with iPhone fundus photography.

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Science, The University of Chicago Medicine & Biological Sciences, 5841 S. Maryland Ave, Chicago, IL, 60637, USA

    Sarah M. Hilkert, Asim V. Farooq & Mark J. Greenwald

Authors
  1. Sarah M. Hilkert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asim V. Farooq
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark J. Greenwald
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah M. Hilkert.

Ethics declarations

Conflict of Interest

Asim Farooq, Sarah Hilkert, and Mark Greenwald declare no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Pediatric Ophthalmology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hilkert, S.M., Farooq, A.V. & Greenwald, M.J. Retinoblastoma: A Global Perspective. Curr Ophthalmol Rep 5, 119–127 (2017). https://doi.org/10.1007/s40135-017-0138-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40135-017-0138-z

Keywords

Search

Navigation